This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: J-Chemical Corporation, Osaka University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1,044 
Years Active: 2022
Title: Kazutoshi Fujita: Innovator in Prostate Cancer Detection
Introduction
Kazutoshi Fujita is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of high-risk prostate cancer. His innovative approach aims to provide essential information for patients undergoing PSA tests.
Latest Patents
Fujita holds a patent for a method, biomarker, and diagnostic agent for the detection of high-risk prostate cancer. The patent addresses the problem of providing useful information, such as the necessity of biopsy, to patients who test positive in a PSA test. The solution involves a method that reacts PSA in urine samples with a specific fucose α1→6 affinitive lectin, which has a defined binding constant for detecting prostate cancer.
Career Highlights
Throughout his career, Kazutoshi Fujita has worked with reputable organizations, including J-Chemical Corporation and Osaka University. His experience in these institutions has contributed to his expertise in medical diagnostics and innovation.
Collaborations
Fujita has collaborated with notable colleagues, including Yuka Kobayashi and Norio Nonomura. Their joint efforts have further advanced research in the field of prostate cancer detection.
Conclusion
Kazutoshi Fujita's work in developing a method for detecting high-risk prostate cancer showcases his commitment to improving patient outcomes. His innovative contributions continue to influence the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile